ASBMR 2021 Rare Bone Disease Highlights

Programme summary

Duration 20 MIN
Downloadable resources Yes
Download PDF
Download PPTX
HCPs enrolled 109 HCPs
Language(s)

Listen to the podcast now

Other episodes of this series

Episode 1: Day 1

ASBMR 2021 Rare Bone Disease Highlights

Episode 2: Day 2

Current Episode

ASBMR 2021 Rare Bone Disease Highlights

Episode 3: Patient Perspectives

ASBMR 2021 Rare Bone Disease Highlights

Episode 4: Full Meeting Coverage

This educational programme is supported by an Independent Medical Education Grant from Ipsen, Kyowa Kirin and Ultragenyx

Email

Specialty

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Prof. Dr Oliver Semler

Programme summary

Other episodes in this series

I agree that this educational programme:

Other programmes of interest

Rare diseases: gene therapy and gene-modified cell therapies

Experts

Pituitary Updates from ECE & ENDO 2023

Experts

Endorsed by

Episode

2

of 2

Primary Biliary Cholangitis Highlights from EASL 2023

Experts

Endorsed by

Episode

1

of 2

Primary Biliary Cholangitis Highlights from EASL 2023

Experts

Endorsed by

Recognising and Diagnosing Severe Primary IGF-I Deficiency (SPIGFD)

Experts

Endorsed by

Episode

3

of 3

ASBMR 2022 Rare Bone Disease Highlights

Experts

ASBMR 2021 Rare Bone Disease Highlights

Episode 2: Day 2

Publication Date

<img src="https://cor2ed.com/cms/wp-content/uploads/2022/06/66p90-5BgyH-Semler-1-150x150.jpg" alt="Prof. Dr Oliver Semler"> Prof. Dr Oliver Semler Paediatric Rheumatologist Children’s Hospital, University of Cologne, Cologne Germany (DE)

Prof. Dr Oliver Semler

Programme summary

Other episodes in this series

Share this programme

I agree that this educational programme:

Other programmes of interest

Rare diseases: gene therapy and gene-modified cell therapies

Experts

Pituitary Updates from ECE & ENDO 2023

Experts

Endorsed by

Episode

2

of 2

Primary Biliary Cholangitis Highlights from EASL 2023

Experts

Endorsed by

Episode

1

of 2

Primary Biliary Cholangitis Highlights from EASL 2023

Experts

Endorsed by

Recognising and Diagnosing Severe Primary IGF-I Deficiency (SPIGFD)

Experts

Endorsed by

Episode

3

of 3

ASBMR 2022 Rare Bone Disease Highlights

Experts